236 - The Latest Advances in Otoprotective Agents with Ting Therapeutics CEO, Dr. Jian Zuo

236 - The Latest Advances in Otoprotective Agents with Ting Therapeutics CEO, Dr. Jian Zuo

Jian Zuo, CEO of Ting Therapeutics, discusses the latest updates on otoprotective agents for three conditions: antibiotic-induced hearing loss, cisplatin-induced hearing loss, and noise-induced hearing loss. Dr. Zuo explains the science behind the company's innovative drug candidates and how they aim to address the unmet need for hearing protection. Zuo provides an overview of Ting Therapeutics’ preclinical research, outlining key findings on TT003 and other investigational compounds. The discussion focuses on the company's research process, detailing the progress of these drug candidates through preclinical testing and examining their potential relevance for patients at risk of hearing loss. Be sure to subscribe to our YouTube channel for the latest episodes each week, and follow This Week in Hearing on LinkedIn and X (formerly Twitter): https://www.linkedin.com/company/this-week-in-hearing/ https://twitter.com/WeekinHearing

Jaksot(350)

263 - Regulation, Innovation, and the Road to Fully Implantable Hearing Devices

263 - Regulation, Innovation, and the Road to Fully Implantable Hearing Devices

Hearing technology is evolving, and fully implantable devices are becoming a reality. In this discussion, Brent Lucas, CEO of Envoy Medical, joins Shari Eberts to talk about the company's fully implan...

17 Helmi 202524min

262 - Can Genetic Research Unlock a Cure for Hearing Loss? Exploring the Future of Personalized Treatment with Dr. Christo Bester

262 - Can Genetic Research Unlock a Cure for Hearing Loss? Exploring the Future of Personalized Treatment with Dr. Christo Bester

Will genetic therapies revolutionize hearing loss treatment? Dr. Christo Bester, Head of Implant Innovation at Ear Science Institute Australia, discusses the emerging role of gene therapy and personal...

11 Helmi 202526min

261 - Hearing Therapeutics in 2025: Where Are We, and What’s Next?

261 - Hearing Therapeutics in 2025: Where Are We, and What’s Next?

Hearing therapeutics are advancing rapidly, but how close are we to real breakthroughs? That was the focus of The State of Hearing Therapeutics, a panel discussion held during the 2025 Hearing Therape...

6 Helmi 202558min

260 - Exploring ReSound Vivia Hearing Aids: AI-Powered Sound, Bluetooth LE Audio, and More

260 - Exploring ReSound Vivia Hearing Aids: AI-Powered Sound, Bluetooth LE Audio, and More

GN’s new ReSound Vivia hearing aids integrate advanced AI to deliver a more adaptive and personalized listening experience. The devices leverage a deep neural network (DNN) trained on 13.5 million spo...

4 Helmi 202526min

259 - Inside the Stanford Initiative to Cure Hearing Loss: Cutting-Edge Science and Innovation

259 - Inside the Stanford Initiative to Cure Hearing Loss: Cutting-Edge Science and Innovation

Hearing loss affects millions worldwide, but could a cure be within reach? Researchers at Stanford’s SICHL are making significant strides in regenerative medicine and innovative therapies to address o...

30 Tammi 202525min

258 - Exploring the Relationship between Hearing Loss and Musicality: Insights from the Vanderbilt Music Cognition Lab

258 - Exploring the Relationship between Hearing Loss and Musicality: Insights from the Vanderbilt Music Cognition Lab

How are hearing loss and musicality connected? In a recent conversation, Brian Taylor spoke with Dr. Srishti Nayak, a researcher at the Vanderbilt Music Cognition Lab, to explore the relationship betw...

28 Tammi 202530min

257 - Transforming Aural Rehabilitation: AI-Powered Auditory Training with LACE AI Pro

257 - Transforming Aural Rehabilitation: AI-Powered Auditory Training with LACE AI Pro

With auditory training gaining renewed attention, Neurotone’s revitalized LACE AI Pro is emerging as a powerful tool for improving hearing outcomes. In this discussion, Dr. Miles Aron, COO of Neuroton...

13 Tammi 202532min

256 - Can Cell Therapy Reverse Hearing Loss? Latest Update on Development of the ReSonance™ Program

256 - Can Cell Therapy Reverse Hearing Loss? Latest Update on Development of the ReSonance™ Program

Can cell therapy revolutionize hearing loss treatment? In this follow-up discussion, Brian Culley, CEO of Lineage Cell Therapeutics, shares exciting updates on the ReSonance™ (ANP1) program, a pioneer...

6 Tammi 202516min

Suosittua kategoriassa Terveys ja hyvinvointi

unicast
tiedenaiset-podcast
psykopodiaa-podcast
voi-hyvin-meditaatiot-2
vakeva-elama-viisaampi-mieli-vahvempi-keho
rss-pitaisko-erota
rss-kuumilla-aalloilla
rss-narsisti
meditaatiot-suomeksi
selviytyjat-tarinoita-elamasta
rss-pt-paahtio
puhu-muru
junnut-pelissa
rss-nautinto
terapiassa
rss-uplevel-by-sonja-hannus
rss-en-saa-unta
rss-sanelunpurku-podcast
yes-girl
rss-fitissa-podcast